Joe Hirman

Jun 24, 2024 | headachejournal.onlinelibrary.wiley.com | Andrew Blumenfeld |David Kudrow |Peter McAllister |Joe Hirman

CM chronic migraine HIT-6 6-item Headache Impact Test ICHD-3β International Classification of Headache Disorders, 3rd edition, beta MIDAS Migraine Disability Assessment MOH medication-overuse headache PGIC Patient Global Impression of Change PI-MBS patient-identified most bothersome symptom SD standard deviation SE standard error SF-36 36-item Short-Form Health Survey INTRODUCTION Medication-overuse headache (MOH) is a secondary headache disorder that develops in some patients who frequently...

Mar 13, 2024 | journals.sagepub.com | Frank Porreca |Edita Navratilova |Joe Hirman |Richard Lipton

Conclusion/InterpretationPublished data evaluating the acute treatment effects of gepant drugs from more than 2595 women and 422 men show significant effects on PF and MBS outcomes in women but the available data do not show significant effects in men. The magnitude of the TE observed was always larger in women than in men. Additionally, the calculated NNTs were higher for men than for women for all gepant studies.